APA (7th ed.) Citation

Casas, R., Tompa, A., Åkesson, K., Teixeira, P. F., Lindqvist, A., & Ludvigsson, J. (2025). Redosing with Intralymphatic GAD-Alum in the Treatment of Type 1 Diabetes: The DIAGNODE-B Pilot Trial. International journal of molecular sciences, 26(1), 374. https://doi.org/10.3390/ijms26010374

Chicago Style (17th ed.) Citation

Casas, Rosaura, Andrea Tompa, Karin Åkesson, Pedro F. Teixeira, Anton Lindqvist, and Johnny Ludvigsson. "Redosing with Intralymphatic GAD-Alum in the Treatment of Type 1 Diabetes: The DIAGNODE-B Pilot Trial." International Journal of Molecular Sciences 26, no. 1 (2025): 374. https://doi.org/10.3390/ijms26010374.

MLA (9th ed.) Citation

Casas, Rosaura, et al. "Redosing with Intralymphatic GAD-Alum in the Treatment of Type 1 Diabetes: The DIAGNODE-B Pilot Trial." International Journal of Molecular Sciences, vol. 26, no. 1, 2025, p. 374, https://doi.org/10.3390/ijms26010374.